Elevated HTLV-1 proviral load (PVL) is thought to be the major risk factor for developing HAM/TSP in HTLV-1 infected subjects, and a high cerebrospinal fluid (CSF) to peripheral blood mononuclear cells (PBMCs) PVL ratio might be diagnostic of the condition. However, the standard method for quantification of HTLV-1 PVL, Real time PCR, has multiple limitations: the inter-assay variability increases at low PVL and low cell numbers in CSF often precludes accurate quantification. Thus, we are evaluating a novel technique, Digital Droplet PCR (ddPCR), as a potentially more reliable tool. For ddPCR, DNA samples are partitioned into thousands of nanoliter -sized droplets, amplified on a thermocycler, queried for fluorescent signal and normalized to a housekeeping gene. Due to the high number of DNA molecules and number of “independent” events (droplets), Poisson algorithms are used to determine absolute copy numbers and are independent of a standard curve. Our results suggest that ddPCR is very accurate: Intraassay variability evaluated by calculating the coefficient of variation of ten replicates of three samples of DNA in three different ranges of PVL (low < 5%, medium 5-10%, and high > 10%) was 13.0%, 7.1% and 9.5%, respectively. Interassay variability, was evaluated by calculating the CV of duplicates of PVL from three independent runs and three independent extractions was 4.5% with a standard deviation of 0.008. Additionally, ddPCR is reliable in quantifying PVL in the CSF where we have confirmed and extended previous observations of increased HTLV-I PVL in CSF of HAM/TSP compared to the periphery.
. 2014 Jan 7;11(Suppl 1):P13. doi: 10.1186/1742-4690-11-S1-P13
Digital droplet PCR for precise quantification of human T-lymphotropic virus 1 proviral loads
Giovanna S Brunetto
1,✉, Raya Massoud
1, Joan Ohayon
1, Kaylan Fenton
1, Irene Cortese
1, Steven Jacobson
1
Giovanna S Brunetto
1Viral Immunology Section, Neuroimmunology Branch, National Institutes of Neurological Disorders and Stroke, Bethesda, MD, USA
Find articles by Giovanna S Brunetto
Raya Massoud
1Viral Immunology Section, Neuroimmunology Branch, National Institutes of Neurological Disorders and Stroke, Bethesda, MD, USA
Find articles by Raya Massoud
Joan Ohayon
1Viral Immunology Section, Neuroimmunology Branch, National Institutes of Neurological Disorders and Stroke, Bethesda, MD, USA
Find articles by Joan Ohayon
Kaylan Fenton
1Viral Immunology Section, Neuroimmunology Branch, National Institutes of Neurological Disorders and Stroke, Bethesda, MD, USA
Find articles by Kaylan Fenton
Irene Cortese
1Viral Immunology Section, Neuroimmunology Branch, National Institutes of Neurological Disorders and Stroke, Bethesda, MD, USA
Find articles by Irene Cortese
Steven Jacobson
1Viral Immunology Section, Neuroimmunology Branch, National Institutes of Neurological Disorders and Stroke, Bethesda, MD, USA
Find articles by Steven Jacobson
1Viral Immunology Section, Neuroimmunology Branch, National Institutes of Neurological Disorders and Stroke, Bethesda, MD, USA
✉
Corresponding author.
Supplement
16th Interntional Conference on Human Retroviruses: HTLV and Related Viruses
Benoit Barbeau
Conference
26-30 June 2013
16th International Conference on Human Retroviruses: HTLV and Related Viruses
Montreal, Canada
Collection date 2014.
Copyright © 2014 Brunetto et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
PMCID: PMC4044173
